Court Orders Scientific Misconduct Labels Removed From Fisher's Work

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 5
Volume 4
Issue 5

WASHINGTON--Bernard Fisher, MD, Distinguished Service Professor of Surgery, University of Pittsburgh, has won a court order requiring that scientific misconduct labels be removed from citations of his papers in federal databases (Cancerlit and Medline).

WASHINGTON--Bernard Fisher, MD, Distinguished Service Professorof Surgery, University of Pittsburgh, has won a court order requiringthat scientific misconduct labels be removed from citations ofhis papers in federal databases (Cancerlit and Medline).

The labels were added at the insistence of the Office of ResearchIntegrity after last year's revelations of misconduct by a Montrealparticipant in NSABP trials headed by Dr. Fisher. The government,through faxes sent to distributors of the databases, will alsoapologize for the labels, stating that Dr. Fisher's own researchhas never been found to be at fault.

Recent Videos
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
Related Content